Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
-.--%-.--%-8.24x3.94x3.54x-6.43x-6.07x 2.08B
0.51%0.58%17.72x2.32x4.09x9.62x11.23x 75.96B
0.65%0.67%22.79x3.55x4.95x14.39x17.77x 49.03B
-.--%-.--%35.94x7.39x12.28x23.37x27.35x 47.88B
3.15%3.23%-58.2x2.68x3.39x10.02x11.68x 43.39B
-.--%-.--%37.93x1.7x3.44x12.89x14.62x 30.8B
-.--%-.--%53.82x4.12x3.4x26.33x23.45x 24.45B
-.--%-.--%-6.64x4.03x9.07x-5.85x-5.46x 22.75B
-.--%0.05%64.19x5.58x6.07x41.78x48.25x 19.24B
-.--%-.--%-36.55x-6.54x17.57x-48.07x-55.04x 16.04B
-.--%-.--%22.86x3.36x4.93x12.83x17.83x 15.87B
0.15%0.15%63.49x25.89x50.48x71.4x73.63x 13.02B
-.--%-.--%17.98x - 3.68x14.22x16.61x 11.74B
-.--%-.--%-102.17x11237.82x11.04x-79.04x-109.09x 10.92B
-.--%-.--%43.35x - - - - 9.61B
2.7%2.95%12.99x1.21x1.91x7.66x10.43x 7.03B
0.34%0.4%30.13x - 8.14x21.59x25.78x 6.17B
-.--%-.--%60.21x7.23x5.86x32.4x43.64x 5.93B
-.--%-.--%-115.99x - - - - 5.72B
Average 0.39% 0.42% 8.19x 753.62x 9.05x 9.36x 9.80x 21.98B
Weighted average by Cap. 0.55% 0.58% 12.68x 323.15x 7.68x 11.77x 12.95x
Biopharmaceuticals